CC, E., SB, H., S, S., & JS, L. (2023). Role for immunotherapy in pretreated, recurrent, metastatic squamous cell carcinoma arising from mature cystic teratoma. Gynecologic oncology reports, 47, 101181. https://doi.org/10.1016/j.gore.2023.101181
Chicago Style (17th ed.) CitationCC, Edwards, Holloway SB, Sethi S, and Lea JS. "Role for Immunotherapy in Pretreated, Recurrent, Metastatic Squamous Cell Carcinoma Arising from Mature Cystic Teratoma." Gynecologic Oncology Reports 47 (2023): 101181. https://doi.org/10.1016/j.gore.2023.101181.
MLA (9th ed.) CitationCC, Edwards, et al. "Role for Immunotherapy in Pretreated, Recurrent, Metastatic Squamous Cell Carcinoma Arising from Mature Cystic Teratoma." Gynecologic Oncology Reports, vol. 47, 2023, p. 101181, https://doi.org/10.1016/j.gore.2023.101181.